tie2 kinase inhibitor bay 826 (Tocris)
Tocris is a verified supplier 
Tocris manufactures this product 
94
Structured Review
Tocris
tie2 kinase inhibitor bay 826
Tie2 Kinase Inhibitor Bay 826, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bay+826/BAY+826/pm41891922-351-54-61
Average 94 stars, based on 6 article reviews
Tie2 Kinase Inhibitor Bay 826, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bay+826/BAY+826/pm41891922-351-54-61
Average 94 stars, based on 6 article reviews
tie2 kinase inhibitor bay 826 - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Blocking Assay:Article Title: Angiopoietin-1 Upregulates Cancer Cell Motility in Colorectal Cancer Liver Metastases through Actin-Related Protein 2/3 Article Snippet: .. We also treated the cells with either 0.4 μM Inhibition:Article Title: Synaptotagmin-like protein 2a regulates lumen formation via Weibel-Palade body apical secretion of angiopoietin-2 during angiogenesis Article Snippet: .. For Tie- 2 inhibition, cells were treated with Concentration Assay:Article Title: Synaptotagmin-like protein 2a regulates lumen formation via Weibel-Palade body apical secretion of angiopoietin-2 during angiogenesis Article Snippet: .. For Tie- 2 inhibition, cells were treated with Phospho-proteomics:Article Title: Angiopoietin–TIE2 feedforward circuit promotes PIK3CA-driven venous malformations Article Snippet: .. To stimulate TIE2 phosphorylation, rhANGPT1 (R&D Systems, 923-AN-025/CF) was reconstituted in PBS and used at the concentrations of 50 ng ml −1 (PIK3CAH1047R expression, Fig. ) or 200 ng ml −1 (FOXO1 A3 expression, Fig. ) for 30 min. To inhibit TIE2 phosphorylation, HUVECs were pretreated with 1 μg ml −1 Article Title: Angiopoietin-TIE2 feedforward circuit promotes PIK3CA-driven venous malformations. Article Snippet: .. To stimulate TIE2 phosphorylation, rhANGPT1 (R&D Systems, 923-AN-025/CF) was reconstituted in PBS and used at the concentrations of 50 ng ml−1 (PIK3CAH1047R expression, Fig. 5e) or 200 ng ml−1 (FOXO1A3 expression, Fig. 5f) for 30 min. To inhibit TIE2 phosphorylation, HUVECs were pretreated with 1 μg ml−1 Expressing:Article Title: Angiopoietin–TIE2 feedforward circuit promotes PIK3CA-driven venous malformations Article Snippet: .. To stimulate TIE2 phosphorylation, rhANGPT1 (R&D Systems, 923-AN-025/CF) was reconstituted in PBS and used at the concentrations of 50 ng ml −1 (PIK3CAH1047R expression, Fig. ) or 200 ng ml −1 (FOXO1 A3 expression, Fig. ) for 30 min. To inhibit TIE2 phosphorylation, HUVECs were pretreated with 1 μg ml −1 Article Title: Angiopoietin-TIE2 feedforward circuit promotes PIK3CA-driven venous malformations. Article Snippet: .. To stimulate TIE2 phosphorylation, rhANGPT1 (R&D Systems, 923-AN-025/CF) was reconstituted in PBS and used at the concentrations of 50 ng ml−1 (PIK3CAH1047R expression, Fig. 5e) or 200 ng ml−1 (FOXO1A3 expression, Fig. 5f) for 30 min. To inhibit TIE2 phosphorylation, HUVECs were pretreated with 1 μg ml−1 |